首页 > 最新文献

Medical alphabet最新文献

英文 中文
B vitamins and homocysteine in cancer patients with solid malignancies before chemotherapy administration 化疗前实体瘤癌症患者体内的 B 族维生素和同型半胱氨酸
Pub Date : 2024-05-10 DOI: 10.33667/2078-5631-2024-7-55-59
O. A. Tikhonova, D. Druzhinin, L. Litvinova, S. Doktorova, N. Todosenko, N. D. Gazatova, M. Bograya, E. L. Naumova, M. I. Dolgaleva
Recently, the role of vitamin imbalance in carcinogenesis has been actively discussed. Studies aimed at assessing their role in the processes of cancer development are various, and the evaluation of the initial level of vitamins is relevant when planning antitumor therapy.Objective. To determine the state of the initial level of B vitamins and homocysteine before chemotherapy in patients of different oncologic profile.Material sand Methods. The level of vitamins B1, B6, B9, active form of B12* and homocysteine in fresh frozen plasma was determined by enzyme[1]linked immunosorbent assay (ELISA) using test systems in 66 patients with verified malignant neoplasms before chemotherapy. The study included 66 patients: women n=40 and men n=26, with cancer: gastric n=12, colorectal cancer n=21, cancer lung n=11, cancer pelvic organs n=22.Results. According to the results of the study the increase in the level of holotranscobalamin (Holo-TC) and decrease in homocysteine in comparison with reference values was observed in 100% of cases. Significant difference was found only for B1: reliable differences between patients with colorectal cancer and with pelvic cancer (in the latter the mean value of B1 levels was 2.4 times higher at p = 0.0425). According to the results of correlation analysis, a weak correlation between B12 and B9 was determined. When comparing the levels of vitamin B12 and homocysteine in patients after surgical treatment and without it, no significant differences were found.Conclusion. Increased Holo-TC levels and decreased homocysteine levels by ELISA are characteristic of all varieties of solid cancer, independent of sex, age, stage and previous surgical intervention. A relative decrease in vitamin B1 is characteristic of colorectal cancer
最近,人们积极讨论了维生素失衡在致癌过程中的作用。旨在评估维生素在癌症发展过程中的作用的研究多种多样,在计划抗肿瘤治疗时,对维生素初始水平的评估具有重要意义。确定不同肿瘤患者化疗前 B 族维生素和同型半胱氨酸的初始水平。采用酶[1]联免疫吸附试验(ELISA)测定化疗前新鲜冰冻血浆中维生素B1、B6、B9、活性形式B12*和同型半胱氨酸的水平。该研究包括66名患者:女性40人,男性26人,癌症:胃癌12人,结直肠癌21人,肺癌11人,盆腔器官癌22人。研究结果表明,与参考值相比,100% 的病例中全反式钴胺素(Holo-TC)水平有所上升,同型半胱氨酸水平有所下降。只有 B1 存在显著差异:结直肠癌患者和盆腔癌患者之间存在可靠的差异(盆腔癌患者的 B1 水平平均值是结直肠癌患者的 2.4 倍,P = 0.0425)。根据相关性分析结果,B12 和 B9 之间存在微弱的相关性。在比较手术治疗后和未手术治疗患者的维生素 B12 和同型半胱氨酸水平时,未发现明显差异。通过酶联免疫吸附试验(ELISA)发现,所有类型的实体瘤都有全维生素 T C 水平升高和同型半胱氨酸水平降低的特征,与性别、年龄、分期和既往手术治疗无关。维生素 B1 的相对减少是结直肠癌的特征。
{"title":"B vitamins and homocysteine in cancer patients with solid malignancies before chemotherapy administration","authors":"O. A. Tikhonova, D. Druzhinin, L. Litvinova, S. Doktorova, N. Todosenko, N. D. Gazatova, M. Bograya, E. L. Naumova, M. I. Dolgaleva","doi":"10.33667/2078-5631-2024-7-55-59","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-7-55-59","url":null,"abstract":"Recently, the role of vitamin imbalance in carcinogenesis has been actively discussed. Studies aimed at assessing their role in the processes of cancer development are various, and the evaluation of the initial level of vitamins is relevant when planning antitumor therapy.Objective. To determine the state of the initial level of B vitamins and homocysteine before chemotherapy in patients of different oncologic profile.Material sand Methods. The level of vitamins B1, B6, B9, active form of B12* and homocysteine in fresh frozen plasma was determined by enzyme[1]linked immunosorbent assay (ELISA) using test systems in 66 patients with verified malignant neoplasms before chemotherapy. The study included 66 patients: women n=40 and men n=26, with cancer: gastric n=12, colorectal cancer n=21, cancer lung n=11, cancer pelvic organs n=22.Results. According to the results of the study the increase in the level of holotranscobalamin (Holo-TC) and decrease in homocysteine in comparison with reference values was observed in 100% of cases. Significant difference was found only for B1: reliable differences between patients with colorectal cancer and with pelvic cancer (in the latter the mean value of B1 levels was 2.4 times higher at p = 0.0425). According to the results of correlation analysis, a weak correlation between B12 and B9 was determined. When comparing the levels of vitamin B12 and homocysteine in patients after surgical treatment and without it, no significant differences were found.Conclusion. Increased Holo-TC levels and decreased homocysteine levels by ELISA are characteristic of all varieties of solid cancer, independent of sex, age, stage and previous surgical intervention. A relative decrease in vitamin B1 is characteristic of colorectal cancer","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140991430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The prevalence of vaginal dysbiosis in women of reproductive age 育龄妇女阴道菌群失调的发病率
Pub Date : 2024-05-10 DOI: 10.33667/2078-5631-2024-8-22-24
A. B. Khuraseva, T. V. Reminnaya
{"title":"The prevalence of vaginal dysbiosis in women of reproductive age","authors":"A. B. Khuraseva, T. V. Reminnaya","doi":"10.33667/2078-5631-2024-8-22-24","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-8-22-24","url":null,"abstract":"","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140993863","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of gas exchange under different modes of ventilation in yoga breathing exercises 瑜伽呼吸练习中不同通气模式下的气体交换研究
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-6-39-46
A. Frolov, I. Manichev, S. Ermolaeva
Yoga breathing exercises that develop the ability to voluntarily regulate the minute volume of respiration (MV) and maintain the state of hypoventilation, hypoxia and hypercapnia, can be considered as a way of hypoxic-hypercapnic training, potentially capable of influencing cerebral circulation and neuroprotective factors. However, at the moment, individual anthropometric features that affect the ability to develop a hypoventilation mode of breathing have not been studied, and methodological criteria for training have not been developed.Methods: The study involved 44 people (32 men and 12 women) who regularly practice yoga breathing techniques with a voluntary decrease in respiratory rate using maximum tidal volume (TV). Free breathing was recorded for 2 minutes, then each subject performed the respiratory hypoventilation pattern available to him or her (minimum RR values with maximum TV, inhalation and exhalation were of equal duration). The following parameters of external respiration were determined: respiratory rate (RR), minute ventilation (MV), tidal volume (TV), partial pressure of CO2 in the exhaled air at the end of exhalation (PetCO2 ), percentage of O2 in the exhaled air (FeO2) and hemoglobin saturation (SpO2 ).Results: Compared to breathing at rest (MV = M±SD 8.51 ± 2.57 (95% CI 7.72–9.29) l/min; PetCO2 = M±SD 36.98 ± 3.71 (95% CI 35.85–38.11) mm Hg), the mode with RR = 3 times/min (inspiration and expiration for 10 s), n = 44, leads to an increase in MV up to M±SD 12.02 ± 3.42 (95% CI 10.98–13.06) l/min (p < 0.001) and a decrease of CO2 : PetCO2 = M±SD 33.99 ± 3.59 (95% CI 32.90–35.08) mm Hg (p < 0.001) — that is, to development of alveolar hypocapnia. The mode with RR = 1.5 times/min (inhalation and exhalation for 20 s), n = 44, demonstrates a decrease in MV to M±SD 5.95 ± 1.59 (95% CI 5.46–6.43) l/min (p < 0.001) and growth of PetCO2 up to M±SD 41.19 ± 3.71 (95% CI 40.06–42.32) mm Hg (p < 0.001). The mode with RR = 1 time/min (inspiration and exhalation for 30 s), n = 24: with a decrease in RR to 1 time/min, a decrease in MV was observed to M±SD 4.22 ± 0.92 (95% CI 3.83–4.61) l / min (p < 0.001) and an increase in PetCO2 up to M±SD 44.05 ± 3.05 (95% CI 42.76–45.33) mm Hg (p < 0.001). The breathing pattern with RR = 1 r/min is accompanied by a statistically significant decrease in MV compared to rest, as well as an increase in PetCO2 and a decrease in FeO2 , that is, it is hypoventilation. We have proposed a ventilation coefficient (Qvent), which is the ratio MV/VC, which allows us to judge at what values of MV an individual reaches a state of hypoventilation. It was previously shown in this sample that the breathing exercise becomes hypoventilation when Qvent values are equal to or less than 1. With Qvent in the range from 1 to 2, the ventilation mode is within normal values, and when Qvent is more than 2, hyperventilation occurs.Conclusion: when performing yoga breathing exercises, variations in MV are observed both in the directi
瑜珈呼吸练习可培养自愿调节微量呼吸(MV)和维持低通气、低氧和高碳酸血症状态的能力,可被视为低氧-高碳酸血症训练的一种方式,有可能对脑循环和神经保护因素产生影响。然而,目前尚未对影响低通气呼吸模式发展能力的个体人体测量特征进行研究,也未制定训练方法标准:这项研究涉及 44 人(32 名男性和 12 名女性),他们定期练习瑜伽呼吸技巧,利用最大潮气量(TV)自愿降低呼吸频率。先记录 2 分钟的自由呼吸,然后每个受试者都采用自己可用的呼吸低通气模式(最大潮气量下的最小呼吸频率值,吸气和呼气的持续时间相同)。测定的外部呼吸参数包括:呼吸频率(RR)、分钟通气量(MV)、潮气量(TV)、呼气末呼出空气中的二氧化碳分压(PetCO2)、呼出空气中的氧气百分比(FeO2)和血红蛋白饱和度(SpO2):与静态呼吸(MV = M±SD 8.51 ± 2.57 (95% CI 7.72-9.29) l/min;PetCO2 = M±SD 36.98 ± 3.71 (95% CI 35.85-38.11) mm Hg)相比,RR = 3 次/min(吸气和呼气 10 秒)的模式(n = 44)导致 MV 增加到 M±SD 12.02 ± 3.42 (95% CI 10.98-13.06) l/min (p < 0.001),CO2 : PetCO2 = M±SD 33.99 ± 3.59 (95% CI 32.90-35.08) mm Hg (p < 0.001),即肺泡低碳酸血症。RR = 1.5 次/分的模式(吸气和呼气 20 秒),n = 44,显示 MV 下降至 M±SD 5.95 ± 1.59 (95% CI 5.46-6.43) l/min (p < 0.001),PetCO2 增长至 M±SD 41.19 ± 3.71 (95% CI 40.06-42.32) mm Hg (p < 0.001)。RR = 1 次/分钟的模式(吸气和呼气 30 秒),n = 24:随着 RR 下降到 1 次/分钟,观察到 MV 下降到 M±SD 4.22 ± 0.92 (95% CI 3.83-4.61) 升/分钟(p < 0.001),PetCO2 上升到 M±SD 44.05 ± 3.05 (95% CI 42.76-45.33) mm Hg(p < 0.001)。与静息时相比,RR = 1 r/min 的呼吸模式伴随着 MV 的显著下降、PetCO2 的上升和 FeO2 的下降,即通气不足。我们提出了通气系数 (Qvent),即 MV/VC 的比值,通过它我们可以判断一个人的 MV 值达到了何种通气不足状态。结论:在进行瑜伽呼吸练习时,可以观察到 MV 的变化,既有过度通气方向的变化,也有低通气方向的变化,并伴有相应的气体交换变化(低碳酸血症伴有过度通气,高碳酸血症伴有低通气)。个人达到换气不足时的肺活量值因人而异,可通过换气系数(Qvent)进行预测。
{"title":"Study of gas exchange under different modes of ventilation in yoga breathing exercises","authors":"A. Frolov, I. Manichev, S. Ermolaeva","doi":"10.33667/2078-5631-2024-6-39-46","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-6-39-46","url":null,"abstract":"Yoga breathing exercises that develop the ability to voluntarily regulate the minute volume of respiration (MV) and maintain the state of hypoventilation, hypoxia and hypercapnia, can be considered as a way of hypoxic-hypercapnic training, potentially capable of influencing cerebral circulation and neuroprotective factors. However, at the moment, individual anthropometric features that affect the ability to develop a hypoventilation mode of breathing have not been studied, and methodological criteria for training have not been developed.Methods: The study involved 44 people (32 men and 12 women) who regularly practice yoga breathing techniques with a voluntary decrease in respiratory rate using maximum tidal volume (TV). Free breathing was recorded for 2 minutes, then each subject performed the respiratory hypoventilation pattern available to him or her (minimum RR values with maximum TV, inhalation and exhalation were of equal duration). The following parameters of external respiration were determined: respiratory rate (RR), minute ventilation (MV), tidal volume (TV), partial pressure of CO2 in the exhaled air at the end of exhalation (PetCO2 ), percentage of O2 in the exhaled air (FeO2) and hemoglobin saturation (SpO2 ).Results: Compared to breathing at rest (MV = M±SD 8.51 ± 2.57 (95% CI 7.72–9.29) l/min; PetCO2 = M±SD 36.98 ± 3.71 (95% CI 35.85–38.11) mm Hg), the mode with RR = 3 times/min (inspiration and expiration for 10 s), n = 44, leads to an increase in MV up to M±SD 12.02 ± 3.42 (95% CI 10.98–13.06) l/min (p < 0.001) and a decrease of CO2 : PetCO2 = M±SD 33.99 ± 3.59 (95% CI 32.90–35.08) mm Hg (p < 0.001) — that is, to development of alveolar hypocapnia. The mode with RR = 1.5 times/min (inhalation and exhalation for 20 s), n = 44, demonstrates a decrease in MV to M±SD 5.95 ± 1.59 (95% CI 5.46–6.43) l/min (p < 0.001) and growth of PetCO2 up to M±SD 41.19 ± 3.71 (95% CI 40.06–42.32) mm Hg (p < 0.001). The mode with RR = 1 time/min (inspiration and exhalation for 30 s), n = 24: with a decrease in RR to 1 time/min, a decrease in MV was observed to M±SD 4.22 ± 0.92 (95% CI 3.83–4.61) l / min (p < 0.001) and an increase in PetCO2 up to M±SD 44.05 ± 3.05 (95% CI 42.76–45.33) mm Hg (p < 0.001). The breathing pattern with RR = 1 r/min is accompanied by a statistically significant decrease in MV compared to rest, as well as an increase in PetCO2 and a decrease in FeO2 , that is, it is hypoventilation. We have proposed a ventilation coefficient (Qvent), which is the ratio MV/VC, which allows us to judge at what values of MV an individual reaches a state of hypoventilation. It was previously shown in this sample that the breathing exercise becomes hypoventilation when Qvent values are equal to or less than 1. With Qvent in the range from 1 to 2, the ventilation mode is within normal values, and when Qvent is more than 2, hyperventilation occurs.Conclusion: when performing yoga breathing exercises, variations in MV are observed both in the directi","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ultrasound vector mapping of common femoral artery blood flow in normal and early-stage stenosis 正常和早期狭窄时股总动脉血流的超声矢量绘图
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-6-47-50
T. Kulagina, E. Dutikova, V. A. Sandrikov, A. V. Gavrilenko, Al-Samsei Naim Nas
It is assumed that the wall shear stress (WSS), which determines the function of the endothelium, is constant along the arterial bed. The assessment of turbulence, blood flow velocity in the arterial system in healthy (13 patients) and in patients with the initial form of atherosclerosis in the femoral artery (42 patients) was discussed. The study quantified blood flow in the common femoral artery using V Flow with visualization of blood flow with a high frame rate. The results obtained in the femoral arteries were evaluated by the wall shear rate, velocity profile and oscillation index (OSI). It was shown that the average value of WSSmean in the femoral artery in healthy and in patients with stenosis <30–35% is 0.9± 0.4 – 0.91±0.4 Pa and does not significantly differ. The wall thickness in the common femoral artery in patients with the initial form of atherosclerosis was 0.9–1.1 mm, and in healthy patients 0.8–0.9 mm. The correlation between the parameters was evaluated by nonparametric analysis of Kendall’s Taub. It was revealed that there is no correlation between WSSmean and blood flow velocity (Vs) in both healthy and patients with the initial form of atherosclerosis.
假设决定内皮功能的壁剪应力(WSS)沿动脉床恒定不变。研究讨论了对健康人(13 名患者)和股动脉初期动脉粥样硬化患者(42 名患者)动脉系统中湍流和血流速度的评估。研究使用 V Flow 对股总动脉中的血流进行了量化,并以高帧率对血流进行了可视化。通过股动脉壁剪切率、速度曲线和振荡指数(OSI)对股动脉的结果进行了评估。结果表明,健康人和血管狭窄<30-35%的患者股动脉中的 WSSmean 平均值为 0.9±0.4 - 0.91±0.4 Pa,并无明显差异。初期动脉粥样硬化患者的股总动脉壁厚度为 0.9-1.1 毫米,健康患者为 0.8-0.9 毫米。通过 Kendall's Taub 非参数分析评估了各参数之间的相关性。结果显示,在健康人和初期动脉粥样硬化患者中,WSSmean 与血流速度(Vs)之间没有相关性。
{"title":"Ultrasound vector mapping of common femoral artery blood flow in normal and early-stage stenosis","authors":"T. Kulagina, E. Dutikova, V. A. Sandrikov, A. V. Gavrilenko, Al-Samsei Naim Nas","doi":"10.33667/2078-5631-2024-6-47-50","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-6-47-50","url":null,"abstract":"It is assumed that the wall shear stress (WSS), which determines the function of the endothelium, is constant along the arterial bed. The assessment of turbulence, blood flow velocity in the arterial system in healthy (13 patients) and in patients with the initial form of atherosclerosis in the femoral artery (42 patients) was discussed. The study quantified blood flow in the common femoral artery using V Flow with visualization of blood flow with a high frame rate. The results obtained in the femoral arteries were evaluated by the wall shear rate, velocity profile and oscillation index (OSI). It was shown that the average value of WSSmean in the femoral artery in healthy and in patients with stenosis <30–35% is 0.9± 0.4 – 0.91±0.4 Pa and does not significantly differ. The wall thickness in the common femoral artery in patients with the initial form of atherosclerosis was 0.9–1.1 mm, and in healthy patients 0.8–0.9 mm. The correlation between the parameters was evaluated by nonparametric analysis of Kendall’s Taub. It was revealed that there is no correlation between WSSmean and blood flow velocity (Vs) in both healthy and patients with the initial form of atherosclerosis.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140994978","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Optimization of the method of introducing anti-adhesion gel “Аntiadhesin” during laparoscopic access in gynecology 在妇科腹腔镜手术中引入防粘连凝胶 "Аntiadhesin "的方法优化
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-8-8-12
A. A. Grigoryants
{"title":"Optimization of the method of introducing anti-adhesion gel “Аntiadhesin” during laparoscopic access in gynecology","authors":"A. A. Grigoryants","doi":"10.33667/2078-5631-2024-8-8-12","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-8-8-12","url":null,"abstract":"","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140997456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Choice of adjuvant therapy for HER2-positive breast cancer in real clinical practice: analysis of physician preferences in the Russian Federation 在实际临床实践中选择 HER2 阳性乳腺癌辅助疗法:俄罗斯联邦医生偏好分析
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-7-7-12
E. Lubennikova, E. Artamonova
Adjuvant therapy with trastuzumab made a significant contribution to improving disease-free and overall survival rates in patients with HER2-positive breast cancer. However, in a number of clinical situations the risk of disease recurrence remains increased. Carrying out neoadjuvant treatment followed by post-neoadjuvant therapy, depending on the degree of pathomorphological response, is the modern standard, allowing to cure a significantly larger number of patients. This became possible thanks to the expansion of the arsenal of terget anti-Her drugs and the introduction into real clinical practice of double anti-HER2 blockade (trastuzumab + pertuzumab) and an antibody conjugate with a cytostatic drug – trastuzumab emtansine. To assess actual clinical practice in the Russian Federation, a survey study “Therapy of HER2-positive breast cancer” was conducted. The survey involved 50 specialists from different regions of the country who are directly involved in developing a treatment plan for patients, which allows them to reflect the preferences of leading chemotherapists regarding tactics for HER2-positive breast cancer. This publication reflects the results of part of the survey, devoted to the choice of adjuvant and post-neoadjuvant therapy for HER2-positive breast cancer. Identified a clear positive trend in favor of neoadjuvant treatment followed by post-neoadjuvant therapy using modern targeted drugs such as pertuzumab and trastuzumab emtansine. The survey results show that 68% of patients with RCB-II–III residual tumor receive post-neoadjuvant trastuzumab emtanzine, in 2021 this figure was only 24%. The absolute majority of patients who have not received neoadjuvant therapy, but have N2–3 stage, receive double anti-HER2 therapy with trastuzumab + pertuzumab in the adjuvant setting. High adherence to the therapy was noted, as 97% of patients complete the planned course of T-DM1, and 91.2% of patients complete a year of adjuvant anti-HER2 therapy. These figures are noticeably higher than the indicators of registration studies. Issues of effectiveness come to the fore in choosing therapy. Issues of drug availability remain relevant, but are not decisive. The survey also revealed factors that were not obvious at first glance and influenced treatment results.
曲妥珠单抗的辅助治疗为提高HER2阳性乳腺癌患者的无病生存率和总生存率做出了重大贡献。然而,在一些临床情况下,疾病复发的风险仍然会增加。根据病理形态学反应的程度,进行新辅助治疗后再进行新辅助治疗是现代的标准,这样可以治愈更多的患者。这要归功于特异性抗 HER 药物库的扩充,以及双抗 HER2 阻滞剂(曲妥珠单抗 + 培妥珠单抗)和细胞抑制药物抗体共轭物--曲妥珠单抗 emtansine 被引入临床实践。为了评估俄罗斯联邦的实际临床实践,开展了一项名为 "HER2 阳性乳腺癌治疗 "的调查研究。来自全国不同地区的 50 名专家参与了此次调查,他们直接参与为患者制定治疗方案,从而反映出主要化疗专家对 HER2 阳性乳腺癌治疗策略的偏好。本刊物反映了部分调查结果,专门讨论了 HER2 阳性乳腺癌辅助治疗和新辅助治疗后的选择。调查发现了一个明显的积极趋势,即倾向于先进行新辅助治疗,然后使用现代靶向药物(如百妥珠单抗和曲妥珠单抗)进行新辅助治疗后的治疗。调查结果显示,68%的RCB-II-III残留肿瘤患者接受了新辅助治疗后的曲妥珠单抗恩坦嗪,而在2021年,这一数字仅为24%。绝大多数未接受新辅助治疗但处于N2-3期的患者在辅助治疗中接受曲妥珠单抗+pertuzumab的双重抗HER2治疗。治疗的依从性很高,97%的患者完成了T-DM1的计划疗程,91.2%的患者完成了一年的抗HER2辅助治疗。这些数字明显高于登记研究的指标。在选择疗法时,疗效问题显得尤为重要。药物供应问题依然重要,但并非决定性因素。调查还揭示了一些乍看之下并不明显但却影响治疗结果的因素。
{"title":"Choice of adjuvant therapy for HER2-positive breast cancer in real clinical practice: analysis of physician preferences in the Russian Federation","authors":"E. Lubennikova, E. Artamonova","doi":"10.33667/2078-5631-2024-7-7-12","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-7-7-12","url":null,"abstract":"Adjuvant therapy with trastuzumab made a significant contribution to improving disease-free and overall survival rates in patients with HER2-positive breast cancer. However, in a number of clinical situations the risk of disease recurrence remains increased. Carrying out neoadjuvant treatment followed by post-neoadjuvant therapy, depending on the degree of pathomorphological response, is the modern standard, allowing to cure a significantly larger number of patients. This became possible thanks to the expansion of the arsenal of terget anti-Her drugs and the introduction into real clinical practice of double anti-HER2 blockade (trastuzumab + pertuzumab) and an antibody conjugate with a cytostatic drug – trastuzumab emtansine. To assess actual clinical practice in the Russian Federation, a survey study “Therapy of HER2-positive breast cancer” was conducted. The survey involved 50 specialists from different regions of the country who are directly involved in developing a treatment plan for patients, which allows them to reflect the preferences of leading chemotherapists regarding tactics for HER2-positive breast cancer. This publication reflects the results of part of the survey, devoted to the choice of adjuvant and post-neoadjuvant therapy for HER2-positive breast cancer. Identified a clear positive trend in favor of neoadjuvant treatment followed by post-neoadjuvant therapy using modern targeted drugs such as pertuzumab and trastuzumab emtansine. The survey results show that 68% of patients with RCB-II–III residual tumor receive post-neoadjuvant trastuzumab emtanzine, in 2021 this figure was only 24%. The absolute majority of patients who have not received neoadjuvant therapy, but have N2–3 stage, receive double anti-HER2 therapy with trastuzumab + pertuzumab in the adjuvant setting. High adherence to the therapy was noted, as 97% of patients complete the planned course of T-DM1, and 91.2% of patients complete a year of adjuvant anti-HER2 therapy. These figures are noticeably higher than the indicators of registration studies. Issues of effectiveness come to the fore in choosing therapy. Issues of drug availability remain relevant, but are not decisive. The survey also revealed factors that were not obvious at first glance and influenced treatment results.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140996153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
New in the prevention of undeveloped pregnanc 预防未发育妊娠的新方法
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-8-13-15
L. Tkachenko, T. A. Verovskaya, N. I. Sviridova, T. I. Kostenko, E. A. Homich
The problem of non-developing pregnancy (NB) remains relevant due to the rather wide spread of this complication and is due to the search for prognostically significant causes of this pathology, the development of adequate prevention of the detected disorders [1–4]. Polymorphic variants of folate genes lead to excessive accumulation of HC in the blood and hypomethylation of DNA, which contributes to an increase in early miscarriage (the frequency of this pathology is 20–25% of all pregnancies). Carrying out periconceptional prophylaxis with high doses of folic acidreduces the level of free HC in the blood, but this technique is effective only when it begins 3 months before conception and in the early stages of embryo and fetus development (up to 12 weeks). The evaluation of laboratory and clinical data in the course of the study confirmed the effectiveness of the use of folic acid at a dose of 800 mcg in a high risk group for the development of NB (pregnant women with hyperhomocysteinemia (GHZ)) 16 weeks before conception and 12 weeks after conception.
不发育妊娠(NB)问题仍然具有现实意义,因为这种并发症的传播范围相当广泛,而且还需要寻找导致这种病症的重要预后原因,并对所发现的病症进行适当的预防[1-4]。叶酸基因的多态变异会导致血液中 HC 的过度积累和 DNA 的低甲基化,从而导致早期流产的增加(这种病症的发生率占所有妊娠的 20-25%)。使用大剂量叶酸进行围孕期预防可降低血液中游离 HC 的水平,但这种方法只有在受孕前 3 个月以及胚胎和胎儿发育早期(12 周内)开始使用时才有效。研究过程中对实验室和临床数据的评估证实,在 NB 高危人群(患有高同型半胱氨酸血症(GHZ)的孕妇)中使用剂量为 800 微克的叶酸是有效的。受孕前 16 周和受孕后 12 周。
{"title":"New in the prevention of undeveloped pregnanc","authors":"L. Tkachenko, T. A. Verovskaya, N. I. Sviridova, T. I. Kostenko, E. A. Homich","doi":"10.33667/2078-5631-2024-8-13-15","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-8-13-15","url":null,"abstract":"The problem of non-developing pregnancy (NB) remains relevant due to the rather wide spread of this complication and is due to the search for prognostically significant causes of this pathology, the development of adequate prevention of the detected disorders [1–4]. Polymorphic variants of folate genes lead to excessive accumulation of HC in the blood and hypomethylation of DNA, which contributes to an increase in early miscarriage (the frequency of this pathology is 20–25% of all pregnancies). Carrying out periconceptional prophylaxis with high doses of folic acidreduces the level of free HC in the blood, but this technique is effective only when it begins 3 months before conception and in the early stages of embryo and fetus development (up to 12 weeks). The evaluation of laboratory and clinical data in the course of the study confirmed the effectiveness of the use of folic acid at a dose of 800 mcg in a high risk group for the development of NB (pregnant women with hyperhomocysteinemia (GHZ)) 16 weeks before conception and 12 weeks after conception.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140997460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effectiveness of the combination of lenvatinib and everolimus in metastatic renal cell carcinoma in patients with resistance to targeted treatment in real clinical practice 在实际临床实践中,来伐替尼和依维莫司联合治疗靶向治疗耐药的转移性肾细胞癌患者的有效性
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-7-18-25
R. Rakhimov, A. V. Sultanbaev, K. Menshikov, A. Nasretdinov, S. Musin, O. Lipatov, V. A. Suravatkin
Every year, 400,000 new cases of renal cell carcinoma (RCC) and 175,000 deaths are registered worldwide. Currently available advanced treatments for RCC have less toxicity than previously used therapeutic agents, but drug resistance remains a clinically significant problem. Drug resistance occurs as a result of angiogenic transition through activation of pathways that do not depend on VEGF targets of most first-line treatments. Lenvatinib with everolimus can fight resistance to increase both progression-free survival and overall survival in patients with metastatic RCC according to clinical studies.
全世界每年新增肾细胞癌(RCC)病例 40 万例,死亡病例 17.5 万例。与以前使用的治疗药物相比,目前可用的 RCC 先进疗法毒性较小,但耐药性仍然是一个严重的临床问题。耐药性的产生是由于血管生成转换途径被激活,而大多数一线治疗方法并不依赖于血管内皮生长因子靶点。根据临床研究,来伐替尼与依维莫司联合用药可以对抗耐药性,从而提高转移性RCC患者的无进展生存期和总生存期。
{"title":"The effectiveness of the combination of lenvatinib and everolimus in metastatic renal cell carcinoma in patients with resistance to targeted treatment in real clinical practice","authors":"R. Rakhimov, A. V. Sultanbaev, K. Menshikov, A. Nasretdinov, S. Musin, O. Lipatov, V. A. Suravatkin","doi":"10.33667/2078-5631-2024-7-18-25","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-7-18-25","url":null,"abstract":"Every year, 400,000 new cases of renal cell carcinoma (RCC) and 175,000 deaths are registered worldwide. Currently available advanced treatments for RCC have less toxicity than previously used therapeutic agents, but drug resistance remains a clinically significant problem. Drug resistance occurs as a result of angiogenic transition through activation of pathways that do not depend on VEGF targets of most first-line treatments. Lenvatinib with everolimus can fight resistance to increase both progression-free survival and overall survival in patients with metastatic RCC according to clinical studies.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140995189","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vacuum fine-needle aspiration biopsy as a method of early detection of thyroid cancer 作为甲状腺癌早期检测方法的真空细针穿刺活检术
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-7-34-40
A. O. Tagil, A. V. Borsukov
Relevance. Malignant neoplasms of the thyroid gland account for 1–3% in the structure of oncological pathology in the territory of the Russian Federation. Fine needle aspiration biopsy of thyroid foci is an integral part of the examination and is included in both foreign and domestic recommendations. However, there is a problem of obtaining uninformative cytological conclusions, and the risk of obtaining false positive and false negative results remains.Objective. To determine the possibilities of using vacuum aspiration fine needle biopsy under ultrasound control in patients with focal thyroid pathology in a multidisciplinary hospital.Materials and methods. From 2021 to 2023, 331 patients with focal thyroid pathology were examined at the clinical base of the Department of Diagnostic and Minimally Invasive Technologies of the Clinical Hospital № 1 in Smolensk. All patients were divided into two clinical groups. Patients of both groups underwent a comprehensive examination, including palpation of the thyroid gland and lymph nodes of the neck, multiparametric ultrasound examination of the thyroid gland, including B – mode, color Doppler mapping, compression elastography, shear wave elastography, laboratory examination (calcitonin level, TSH, T3, T4, antibodies of TPO, AtTTP, thyroglobulin). In patients who had previously undergone surgical treatment, ultrasound was performed to determine areas of thyroid tissue, and additionally the level of thyroglobulin was determined as a marker of the recurrent process.Results. The median size of the thyroid formation was 15.2 (13.9–19.1) mm. Mainly multiple foci of thyroid gland were detected in both the control group – 106 (79.1%) and the main 107 (54.3%) patients, the share of single foci accounted for 28 (20.9%) of the control and 90 (45.7%) of the main groups. Fine – needle aspiration biopsy was performed using the «Free hand» method using type syringe with a volume of 10 ml. During the vacuum fine – needle aspiration biopsy, depending on the data of the multiparametric ultrasound examination, the level of negative pressure in the range from –0.3 bar to –0.8 bar was determined. At a pressure of –0.3 bar, 54 (27.4%) were performed,–0.5 bar – 126 (64.0%),–0.8 bar – 17 (8.6%) vacuum fine – needle aspiration biopsy.Conclusions. A device has been developed for the implementation of vacuum fine – needle aspiration biopsy with the creation of an improved technique for conducting vacuum fine – needle aspiration biopsy in focal thyroid pathology. The informative value of the method of routine fine – needle aspiration biopsy and vacuum fine – needle aspiration biopsy under ultrasound control in patients with focal thyroid pathology was evaluated. The sensitivity and specificity of fine – needle aspiration biopsy was 75.0% and 52.9%, respectively. The sensitivity and specificity of vacuum fine – needle aspiration biopsy during the study were 95.6% and 92.5%, respectively. The data obtained indicate the effectiveness
相关性。在俄罗斯联邦境内的肿瘤病理学结构中,甲状腺恶性肿瘤占 1-3%。甲状腺病灶的细针穿刺活检是检查中不可或缺的一部分,已被纳入国外和国内的建议中。然而,目前还存在细胞学结论信息不全的问题,而且仍存在获得假阳性和假阴性结果的风险。确定在超声控制下对多学科医院甲状腺局灶性病变患者进行真空吸引细针活检的可能性。从2021年到2023年,斯摩棱斯克第一临床医院诊断与微创技术部临床基地共对331名甲状腺病灶患者进行了检查。所有患者被分为两组。两组患者均接受了全面检查,包括甲状腺和颈部淋巴结触诊、甲状腺多参数超声波检查(包括B型、彩色多普勒成像、压缩弹性成像、剪切波弹性成像)、实验室检查(降钙素水平、促甲状腺激素、T3、T4、TPO抗体、ATTTP、甲状腺球蛋白)。对于曾经接受过手术治疗的患者,则通过超声波检查来确定甲状腺组织的区域,此外还测定甲状腺球蛋白的水平,作为复发过程的标志。甲状腺形成的中位尺寸为 15.2(13.9-19.1)毫米。在对照组106例(79.1%)和主要组107例(54.3%)患者中发现的主要是甲状腺多发病灶,单发病灶占对照组的28例(20.9%)和主要组的90例(45.7%)。细针穿刺活检采用 "徒手 "法,使用容量为 10 毫升的注射器。在真空细针穿刺活检过程中,根据多参数超声波检查的数据,确定负压水平在-0.3 巴到-0.8 巴之间。在-0.3巴的压力下,进行了54例(27.4%)、-0.5巴-126例(64.0%)、-0.8巴-17例(8.6%)真空细针穿刺活检。通过改进甲状腺病灶真空细针穿刺活检技术,开发了一种真空细针穿刺活检设备。对甲状腺病灶患者在超声控制下进行常规细针穿刺活检和真空细针穿刺活检的信息价值进行了评估。细针穿刺活检的敏感性和特异性分别为75.0%和52.9%。研究期间,真空细针穿刺活检的敏感性和特异性分别为 95.6% 和 92.5%。所获得的数据表明该方法是有效的。
{"title":"Vacuum fine-needle aspiration biopsy as a method of early detection of thyroid cancer","authors":"A. O. Tagil, A. V. Borsukov","doi":"10.33667/2078-5631-2024-7-34-40","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-7-34-40","url":null,"abstract":"Relevance. Malignant neoplasms of the thyroid gland account for 1–3% in the structure of oncological pathology in the territory of the Russian Federation. Fine needle aspiration biopsy of thyroid foci is an integral part of the examination and is included in both foreign and domestic recommendations. However, there is a problem of obtaining uninformative cytological conclusions, and the risk of obtaining false positive and false negative results remains.Objective. To determine the possibilities of using vacuum aspiration fine needle biopsy under ultrasound control in patients with focal thyroid pathology in a multidisciplinary hospital.Materials and methods. From 2021 to 2023, 331 patients with focal thyroid pathology were examined at the clinical base of the Department of Diagnostic and Minimally Invasive Technologies of the Clinical Hospital № 1 in Smolensk. All patients were divided into two clinical groups. Patients of both groups underwent a comprehensive examination, including palpation of the thyroid gland and lymph nodes of the neck, multiparametric ultrasound examination of the thyroid gland, including B – mode, color Doppler mapping, compression elastography, shear wave elastography, laboratory examination (calcitonin level, TSH, T3, T4, antibodies of TPO, AtTTP, thyroglobulin). In patients who had previously undergone surgical treatment, ultrasound was performed to determine areas of thyroid tissue, and additionally the level of thyroglobulin was determined as a marker of the recurrent process.Results. The median size of the thyroid formation was 15.2 (13.9–19.1) mm. Mainly multiple foci of thyroid gland were detected in both the control group – 106 (79.1%) and the main 107 (54.3%) patients, the share of single foci accounted for 28 (20.9%) of the control and 90 (45.7%) of the main groups. Fine – needle aspiration biopsy was performed using the «Free hand» method using type syringe with a volume of 10 ml. During the vacuum fine – needle aspiration biopsy, depending on the data of the multiparametric ultrasound examination, the level of negative pressure in the range from –0.3 bar to –0.8 bar was determined. At a pressure of –0.3 bar, 54 (27.4%) were performed,–0.5 bar – 126 (64.0%),–0.8 bar – 17 (8.6%) vacuum fine – needle aspiration biopsy.Conclusions. A device has been developed for the implementation of vacuum fine – needle aspiration biopsy with the creation of an improved technique for conducting vacuum fine – needle aspiration biopsy in focal thyroid pathology. The informative value of the method of routine fine – needle aspiration biopsy and vacuum fine – needle aspiration biopsy under ultrasound control in patients with focal thyroid pathology was evaluated. The sensitivity and specificity of fine – needle aspiration biopsy was 75.0% and 52.9%, respectively. The sensitivity and specificity of vacuum fine – needle aspiration biopsy during the study were 95.6% and 92.5%, respectively. The data obtained indicate the effectiveness ","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140994265","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The use of medical thermal imaging in assessing the dynamics of healing of pressure ulcers in patients with severe brain damage 利用医用热成像技术评估严重脑损伤患者压疮的愈合动态
Pub Date : 2024-05-09 DOI: 10.33667/2078-5631-2024-6-58-62
A. Yakovleva, A. Shestopalov, I. Dolgov
Patients with severe brain damage often develop pressure ulcers (PU). The phases of the wound process significantly extend in time due to the underlying disease, severity of the condition and metabolic changes. Medical thermal imaging can be used to assess the level of PU microcirculation.Aims: to study the possibility of using medical thermal imaging to predict the course of PU in patients after severe brain damage.Methods: 38 ICU patients after brain injury and stage III–IV PU (25 men, 13 women, mean age 59±17 years). The series of thermograms (native image, after the “cold test” and 3 minutes after) were recorded before treatment and after 21 days. We used an NEC ThermoTracer TH 9100 thermal imager.Results. We assessed the minimum/maximum overall temperatures and in the 1st–4th quartiles. With a positive outcome, the temperatures Q3-Q4 were higher (35.1 C–37.6 C versus 34.8 C–36.7 C for a negative outcome) and the lower thresholds of all quartiles. We hypothesized that a sign of PU healing is a narrowing of the range of temperature points on the surface of the wound. We used a point system for assessing the dynamics of temperature parameters, then checked the model using ROC analysis: the AUC was 0.932 (0.81–1.0), which indicates the high quality. The best ratio of sensitivity and specificity (0.81; 0.83) corresponds to a cut-off point of 9.5.Conclusion. The use of medical thermal imaging makes it possible to objectively assess the level of blood supply to the PU in patients after severe brain damage, as well as the prognosis of further wound healing.
严重脑损伤患者经常会出现压疮(PU)。由于潜在疾病、病情严重程度和新陈代谢的变化,伤口过程的各个阶段在时间上会明显延长。医学热成像可用于评估压疮微循环水平。目的:研究使用医学热成像预测重度脑损伤患者压疮病程的可能性。方法:38 名重症监护病房脑损伤和 III-IV 期压疮患者(25 名男性,13 名女性,平均年龄 59±17 岁)。在治疗前和治疗 21 天后记录一系列热图(原始图像、"冷试验 "后和 3 分钟后)。我们使用的是 NEC ThermoTracer TH 9100 热成像仪。我们评估了整体温度的最低/最高值以及第 1-4 个四分位数。结果为阳性时,第 3-4 季度的温度较高(35.1 摄氏度-37.6 摄氏度,而结果为阴性时为 34.8 摄氏度-36.7 摄氏度),所有四分位数的阈值较低。我们假设 PU 愈合的标志是伤口表面温度点的范围缩小。我们采用积分系统评估温度参数的动态变化,然后使用 ROC 分析检验模型:AUC 为 0.932(0.81-1.0),表明模型质量很高。灵敏度和特异性的最佳比率(0.81; 0.83)与 9.5 临界点相对应。使用医用热成像可以客观地评估严重脑损伤后患者的 PU 供血水平以及伤口进一步愈合的预后。
{"title":"The use of medical thermal imaging in assessing the dynamics of healing of pressure ulcers in patients with severe brain damage","authors":"A. Yakovleva, A. Shestopalov, I. Dolgov","doi":"10.33667/2078-5631-2024-6-58-62","DOIUrl":"https://doi.org/10.33667/2078-5631-2024-6-58-62","url":null,"abstract":"Patients with severe brain damage often develop pressure ulcers (PU). The phases of the wound process significantly extend in time due to the underlying disease, severity of the condition and metabolic changes. Medical thermal imaging can be used to assess the level of PU microcirculation.Aims: to study the possibility of using medical thermal imaging to predict the course of PU in patients after severe brain damage.Methods: 38 ICU patients after brain injury and stage III–IV PU (25 men, 13 women, mean age 59±17 years). The series of thermograms (native image, after the “cold test” and 3 minutes after) were recorded before treatment and after 21 days. We used an NEC ThermoTracer TH 9100 thermal imager.Results. We assessed the minimum/maximum overall temperatures and in the 1st–4th quartiles. With a positive outcome, the temperatures Q3-Q4 were higher (35.1 C–37.6 C versus 34.8 C–36.7 C for a negative outcome) and the lower thresholds of all quartiles. We hypothesized that a sign of PU healing is a narrowing of the range of temperature points on the surface of the wound. We used a point system for assessing the dynamics of temperature parameters, then checked the model using ROC analysis: the AUC was 0.932 (0.81–1.0), which indicates the high quality. The best ratio of sensitivity and specificity (0.81; 0.83) corresponds to a cut-off point of 9.5.Conclusion. The use of medical thermal imaging makes it possible to objectively assess the level of blood supply to the PU in patients after severe brain damage, as well as the prognosis of further wound healing.","PeriodicalId":18337,"journal":{"name":"Medical alphabet","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-05-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140996946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Medical alphabet
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1